Targeting ferroptosis in hepatocellular carcinoma

被引:9
|
作者
Mo, Yuqian [1 ]
Zou, Zhilin [2 ]
Chen, Erbao [3 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Zhanjiang 524023, Guangdong, Peoples R China
[2] Wenzhou Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen 518036, Guangdong, Peoples R China
关键词
Ferroptosis; Hepatocellular carcinoma; Immunotherapy; Immune microenvironment; SUPPRESSOR-CELLS; LIPID-PEROXIDATION; T-CELLS; 1ST-LINE TREATMENT; CANCER; DYSFUNCTION; SORAFENIB; ZIP14; TRANSPORTER; SENSITIVITY;
D O I
10.1007/s12072-023-10593-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [41] Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
    Li, Zhong-jie
    Dai, Hui-qi
    Huang, Xiao-wei
    Feng, Ji
    Deng, Jing-huan
    Wang, Zi-xuan
    Yang, Xiao-mei
    Liu, Yu-jia
    Wu, Yong
    Chen, Pan-hong
    Shi, Huan
    Wang, Ji-gang
    Zhou, Jing
    Lu, Guo-dong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (02) : 301 - 310
  • [42] The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
    Liu, Zhili
    Ma, Huihan
    Lai, Zelin
    MOLECULES, 2023, 28 (04):
  • [43] Solanum torvum induces ferroptosis to suppress hepatocellular carcinoma
    Lai, Hsiang-Chun
    Weng, Jui-Chun
    Huang, Hui-Chi
    Ho, Jin-Xuan
    Kuo, Chao-Lin
    Cheng, Ju-Chien
    Huang, Sheng-Teng
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 335
  • [44] Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
    Ma, Shiwen
    Adzavon, Yao Mawulikplimi
    Wen, Xiaohu
    Zhao, Pengxiang
    Xie, Fei
    Liu, Mengyu
    Ma, Xuemei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [45] New perspectives on ferroptosis and its role in hepatocellular carcinoma
    Cong, Tianhao
    Luo, Yingen
    Fu, Yan
    Liu, Yu
    Li, Yujie
    Li, Xiao
    CHINESE MEDICAL JOURNAL, 2022, 135 (18) : 2157 - 2166
  • [46] Targeting ferroptosis: a promising approach for treating lung carcinoma
    Ziyang Wu
    Yan Zhang
    Wendi Zhong
    Kunjian Wu
    Tian Zhong
    Tao Jiang
    Cell Death Discovery, 11 (1)
  • [47] Targeting cannabinoid receptors in hepatocellular carcinoma?
    Mallat, Ariane
    Lotersztajn, Sophie
    GUT, 2016, 65 (10) : 1582 - U399
  • [48] Targeting Signalling Pathways in Hepatocellular Carcinoma
    Blagotinsek, Kaja
    Rozman, Damjana
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (01) : 170 - 175
  • [49] Targeting the hedgehog pathway in hepatocellular carcinoma
    不详
    CANCER BIOLOGY & THERAPY, 2006, 5 (05) : 464 - 464
  • [50] Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
    Eso, Yuji
    INTERNAL MEDICINE, 2021, 60 (03) : 321 - 322